These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35615532)

  • 1. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
    Sun Q; Liu X; Peng Q; Hu L; Jiang X
    J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Li L; Wang X; Ding Y; Hui N; Su B; Yang M
    Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma.
    Li J; Sun X; Lv M; Han Z; Zhong X; Zhang W; Hu R; Feng W; Ma M; Huang Q; Zhou X
    BMC Gastroenterol; 2024 Aug; 24(1):265. PubMed ID: 39143462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.
    Wang X; Wu S; Yang Y; Zhao J
    Oxid Med Cell Longev; 2022; 2022():9277360. PubMed ID: 36254230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma.
    Fang W; Gan Y; Zhang L; Xiong J
    Front Oncol; 2022; 12():853026. PubMed ID: 35574298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
    Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
    Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
    Sun Q; Fu C; Liu J; Li S; Zheng J
    Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
    Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
    Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma.
    Xi G; Cheng R; Liang L; Che N; Wang Y; Zhao N; Liang X; Shao B; Zhao X; Zhang D
    Sci Rep; 2023 Apr; 13(1):6957. PubMed ID: 37117215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
    Lin YR; Yang WJ; Yang GW
    Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma.
    Guo Z; Zhu Z
    Aging (Albany NY); 2022 May; 14(9):3973-3988. PubMed ID: 35511171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-1 Na
    Zhou YT; Chen H; Ai M; Li SS; Li BY; Zhao Y; Cai WW; Hou B; Ni LL; Xu F; Qiu LY
    Life Sci; 2021 Aug; 278():119613. PubMed ID: 34000263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 16. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.
    Liu F; Wu Y; Liu J; Ni RJ; Yang AG; Bian K; Zhang R
    Biochem Biophys Res Commun; 2020 Jun; 527(2):474-480. PubMed ID: 32334831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review.
    Liu S; Miao M; Kang L
    Medicine (Baltimore); 2023 Jan; 102(2):e32625. PubMed ID: 36637946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
    Li Y; Gu A; Yang L; Wang Q
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma.
    Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B
    Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
    Wang B; Chen L; Li Q; Zhou J; Jin W
    Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.